• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Introduction to 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine (CAS No. 1214330-71-8) in Modern Chemical Research

2,3,4-Trifluoro-6-(trifluoromethyl)pyridine, identified by the chemical abstracts service number CAS No. 1214330-71-8, is a fluorinated pyridine derivative that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its trifluoromethyl and trifluoro substituents on a pyridine backbone, exhibits unique electronic and steric properties that make it a valuable scaffold for the development of novel bioactive molecules.

The structural motif of 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine incorporates three fluorine atoms at the 2, 3, and 4 positions of the pyridine ring, along with a trifluoromethyl group at the 6-position. This extensive fluorination imparts high lipophilicity and metabolic stability, which are critical factors in drug design. The presence of fluorine atoms also enhances the compound's binding affinity to biological targets, making it an attractive candidate for medicinal chemistry applications.

In recent years, there has been a surge in research focused on fluorinated heterocycles due to their diverse pharmacological properties. 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine has been extensively studied for its potential as an intermediate in the synthesis of small-molecule inhibitors targeting various therapeutic areas. For instance, studies have demonstrated its utility in developing kinase inhibitors, where the trifluoromethyl group contributes to improved binding interactions with the enzyme active site.

One of the most compelling aspects of 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine is its role in enhancing the bioavailability and pharmacokinetic profiles of drug candidates. The electron-withdrawing nature of fluorine atoms can modulate the electronic properties of adjacent functional groups, leading to optimized pharmacological activity. This has been particularly evident in the development of antiviral and anticancer agents, where fluorinated pyridines have shown promise in preclinical studies.

Recent advancements in synthetic methodologies have further expanded the applications of 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine. Transition-metal-catalyzed cross-coupling reactions have enabled efficient functionalization of this scaffold, allowing for rapid diversification of its chemical library. These techniques have been instrumental in generating novel analogs with enhanced potency and selectivity for biological targets.

The agrochemical sector has also benefited from the use of 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine as a key intermediate in the synthesis of advanced pesticides and herbicides. The structural features of this compound contribute to its efficacy against a broad spectrum of pests while maintaining environmental safety. This aligns with global efforts to develop sustainable agricultural solutions that minimize ecological impact.

Looking ahead, the future prospects for 2,3,4-Trifluoro-6-(trifluoromethyl)pyridine are promising. Ongoing research aims to uncover new therapeutic applications and optimize synthetic routes for large-scale production. Collaborative efforts between academia and industry are expected to drive innovation in this field, leading to the discovery of next-generation pharmaceuticals and agrochemicals.

In conclusion,2,3,4-Trifluoro-6-(trifluoromethyl)pyridine (CAS No. 1214330-71-8) represents a cornerstone compound in modern chemical research. Its unique structural features and versatile applications make it indispensable in drug discovery and agricultural science. As research continues to evolve，this compound is poised to play an increasingly pivotal role in addressing global health and sustainability challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)